Nautilus Biotechnology, Inc. NAUT
Set alert
As of Nov 2, 11:11 AM ET
- YTD
- +23.59%
- 1 year
- +81.21%
- Open
- 2.73
- Prev close
- 2.73
- Mkt cap
- 306.98M
- Vol
- 3.22M
- Avg vol
- 5.35M
- EPS
- -0.46
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.35
- High
- 2.75
- Forward P/E
- -2.32
- Beta
- 1.04
- Short ratio
- 9.26
- Inst. own
- 50.19%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jul 30, 2024
- 50-d avg
- 2.42
- 200-d avg
- 2.56
- 1y target
- 3.44
5D chart
Signals (90)
| Name | Time | Ago |
|---|---|---|
| MACD: Sell Signal | Nov 2, 10:40 AM | 31 minutes ago |
| SMA: Bearish | Nov 2, 10:35 AM | 36 minutes ago |
| MACD: Buy Signal | Nov 2, 10:25 AM | 46 minutes ago |
| SMA: Bullish | Nov 2, 10:05 AM | 1 hour ago |
| RSI: Oversold | Nov 2, 9:35 AM | 1 hour ago |
| SMA: Bearish | Nov 2, 9:30 AM | 1 hour ago |
| SMA: Bearish | Nov 2, 9:30 AM | 1 hour ago |
| MACD: Sell Signal | Nov 2, 9:30 AM | 1 hour ago |
| SMA: Bullish | Oct 30, 3:05 PM | 2 days ago |
| SMA: Bullish | Oct 30, 3:05 PM | 2 days ago |
| SMA: Bullish | Oct 30, 2:40 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 2:40 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 2:20 PM | 2 days ago |
| SMA: Bearish | Oct 30, 2:05 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:45 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:05 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:15 PM | 2 days ago |
| SMA: Bearish | Oct 30, 11:20 AM | 3 days ago |
| SMA: Bullish | Oct 30, 11:05 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:50 AM | 3 days ago |
| MACD: Buy Signal | Oct 30, 10:45 AM | 3 days ago |
| SMA: Bullish | Oct 30, 10:40 AM | 3 days ago |
| RSI: Oversold | Oct 30, 10:05 AM | 3 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 9:30 AM | 3 days ago |
| RSI: Oversold | Oct 30, 9:30 AM | 3 days ago |
| SMA: Bearish | Oct 29, 3:55 PM | 3 days ago |
| SMA: Bullish | Oct 29, 3:50 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 3:50 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 3:10 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:55 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:55 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 2:45 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:20 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 1:20 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 1:00 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:40 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:05 PM | 4 days ago |
| MACD: Sell Signal | Oct 29, 12:05 PM | 4 days ago |
| SMA: Bullish | Oct 29, 11:20 AM | 4 days ago |
| MACD: Buy Signal | Oct 29, 11:20 AM | 4 days ago |
| SMA: Bullish | Oct 29, 11:10 AM | 4 days ago |
| SMA: Bearish | Oct 29, 11:05 AM | 4 days ago |
| SMA: Bearish | Oct 29, 11:05 AM | 4 days ago |
| SMA: Bullish | Oct 29, 11:00 AM | 4 days ago |
| SMA: Bullish | Oct 29, 11:00 AM | 4 days ago |
| SMA: Bearish | Oct 29, 10:45 AM | 4 days ago |
| SMA: Bearish | Oct 29, 10:45 AM | 4 days ago |
| SMA: Bullish | Oct 29, 10:35 AM | 4 days ago |
| SMA: Bullish | Oct 29, 10:35 AM | 4 days ago |
| SMA: Bearish | Oct 29, 10:25 AM | 4 days ago |
| SMA: Bearish | Oct 29, 10:25 AM | 4 days ago |
| SMA: Bullish | Oct 29, 10:10 AM | 4 days ago |
| SMA: Bullish | Oct 29, 10:10 AM | 4 days ago |
| SMA: Bearish | Oct 29, 9:55 AM | 4 days ago |
| MACD: Sell Signal | Oct 29, 9:45 AM | 4 days ago |
| SMA: Bearish | Oct 29, 9:40 AM | 4 days ago |
| SMA: Bullish | Oct 29, 9:30 AM | 4 days ago |
| SMA: Bearish | Oct 28, 3:55 PM | 4 days ago |
| RSI: Overbought | Oct 28, 3:35 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:20 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:55 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:55 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:45 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 2:25 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 1:20 PM | 4 days ago |
| SMA: Bullish | Oct 28, 1:15 PM | 4 days ago |
| SMA: Bearish | Oct 28, 1:00 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:50 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:50 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:05 PM | 5 days ago |
| MACD: Sell Signal | Oct 28, 12:05 PM | 5 days ago |
| MACD: Buy Signal | Oct 28, 10:50 AM | 5 days ago |
| SMA: Bearish | Oct 28, 10:00 AM | 5 days ago |
| MACD: Sell Signal | Oct 28, 10:00 AM | 5 days ago |
| SMA: Bearish | Oct 28, 9:55 AM | 5 days ago |
| SMA: Bullish | Oct 28, 9:30 AM | 5 days ago |
| MACD: Buy Signal | Oct 28, 9:30 AM | 5 days ago |
| RSI: Overbought | Oct 28, 9:30 AM | 5 days ago |
| SMA: Bearish | Oct 27, 3:45 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 3:45 PM | 5 days ago |
| RSI: Overbought | Oct 27, 3:10 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 2:05 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:55 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:50 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 1:45 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:30 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:25 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:15 PM | 5 days ago |
| RSI: Overbought | Oct 27, 12:55 PM | 5 days ago |
News
4 days ago seekingalpha.com
Nautilus Biotechnology: Bullish On Voyager's Upcoming Launch
NAUT is extending Voyager from tau into oncology, which I think will give it more applications for its targeted proteoform platform. NAUT also has research collaborations and SEEDS participation. In…
5 days ago seekingalpha.com
Nautilus Biotechnology, Inc. (NAUT) Q3 2026 Earnings Call Transcript
Nautilus Biotechnology, Inc. (NAUT) Q3 2026 Earnings Call Transcript
6 days ago marketbeat.com
Nautilus Biotechnology Q3 Earnings Call Highlights
Nautilus Biotechnology NASDAQ: NAUT reported third-quarter revenue of $200,000 as it continued its transition toward commercialization of its Voyager proteomics platform, with management reaffirming…
6 days ago benzinga.com
Nautilus Biotechnology Q3 2026 Earnings Call Transcript
Nautilus Biotechnology (NASDAQ:NAUT) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.Benzinga APIs provide…
-
6 days ago benzinga.com
Nautilus Biotechnology Announces Participation In SEEDS Research Consortium, Which Was Awarded Up To $51.7M By The Advanced Research Projects Agency For Health
Nautilus Biotechnology, Inc. (NASDAQ:NAUT), a company pioneering intact, single-molecule proteomics approaches, today announced its participation in SEEDS (Sequence-to-disease: Environment-aware…
6 days ago globenewswire.com
Nautilus Biotechnology Reports Third Quarter 2026 Financial Results
SEATTLE, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the…
6 days ago globenewswire.com
Nautilus to Measure Proteoforms Driving Alzheimer's Disease and Cancer in ARPA-H-Funded SEEDS Consortium
Nautilus expects to receive up to $6 million to bring its Voyager™ Platform to a multidisciplinary team integrating protein science, AI, and computational modeling to develop new diagnostics and…
6 days ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Surgery Partners (NASDAQ:SGRY) shares moved upwards by 46.9% to $23.14 during Monday's regular session. The market value of their outstanding shares is at $2.0 billion. SciSparc (NASDAQ:SPRC)…
1 week ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Bolt Biotherapeutics (NASDAQ:BOLT) shares moved upwards by 58.8% to $6.65 during Friday's regular session. The market value of their outstanding shares is at $7.9 million. Lucid Diagnostics…
1 week ago benzinga.com
Winnebago Industries Posts Upbeat Q4 Earnings, Joins SpaceX, Super Micro Computer And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were mixed as the Dow gained 400 points. Winnebago jumped 7% on an EPS beat, while Super Micro and SpaceX rallied on strong outlooks.
2 weeks ago globenewswire.com
Nautilus Biotechnology to Announce Third Quarter 2026 Financial Results on October 27, 2026
SEATTLE, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report…
3 weeks ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Quantum-Si (NASDAQ:QSI) stock rose 30.3% to $1.59 during Friday's regular session. The company's market cap stands at $267.0 million. Nautilus Biotechnology (NASDAQ:NAUT) stock rose 26.09% to…
-
3 weeks ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) shares increased by 186.0% to $3.58 during Wednesday's regular session. Sunshine Biopharma (NASDAQ:SBFM) stock moved upwards by 151.31% to $1.0. The…
4 weeks ago defenseworld.net
Nautilus Biotechnology Sees Unusually High Options Volume (NASDAQ:NAUT)
Nautilus Biotechnology, Inc. (NASDAQ: NAUT - Get Free Report) was the target of unusually large options trading on Monday. Stock traders bought 3,253 call options on the stock. This represents an…
-
1 month ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Anbio Biotechnology (NASDAQ:NNNN) stock moved upwards by 16.9% to $6.49 during Friday's after-market session. The market value of their outstanding shares is at $276.0 million. Stablecoin…
1 month ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Stablecoin Development (AMEX:SDEV) shares moved upwards by 66.9% to $6.11 during Friday's regular session. The company's market cap stands at $99.2 million. QTREX Quantum (NASDAQ:QTEX) stock…
1 month ago investorplace.com
Neuralink Stock: How to Invest Before the IPO
You can't buy Neuralink stock yet, but its supply chain is already public. Here are the brain-computer interface stocks to watch before the Neuralink IPO.
-
1 month ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers NewGenIvf Group (NASDAQ:NIVF) shares moved upwards by 106.0% to $0.15 during Wednesday's pre-market session. Connect Biopharma Hldgs (NASDAQ:CNTB) stock increased by 79.43% to $1.78. The…
-
1 month ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Stablecoin Development (AMEX:SDEV) stock increased by 121.6% to $3.48 during Tuesday's regular session. The market value of their outstanding shares is at $42.5 million. Iovance…
1 month ago benzinga.com
This SpaceX Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Analysts initiate coverage: Buy on Nautilus ($3.50) and SpaceX ($200); Outperform on FuelCell ($24) and Butterfly ($15); Market Perform on O’Reilly ($94).
-
1 month ago benzinga.com
Roth Capital Initiates Coverage On Nautilus Biotechnology with Buy Rating, Announces Price Target of $3.5
Roth Capital analyst Max Masucci initiates coverage on Nautilus Biotechnology (NASDAQ:NAUT) with a Buy rating and announces Price Target of $3.5.
-
1 month ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Opus Genetics (NASDAQ:IRD) shares increased by 31.7% to $5.71 during Wednesday's regular session. The company's market cap stands at $361.0 million. bioAffinity Technologies (NASDAQ:BIAF)…
-
1 month ago benzinga.com
Leerink Partners Initiates Coverage On Nautilus Biotechnology with Outperform Rating, Announces Price Target of $4
Leerink Partners analyst Puneet Souda initiates coverage on Nautilus Biotechnology (NASDAQ:NAUT) with a Outperform rating and announces Price Target of $4.
1 month ago globenewswire.com
Nature Methods Publication Reveals Deep Insights into Functional Biology through First-of-its-Kind Quantification of Tau Proteoforms
First large-scale, single-molecule analysis of the tau proteoform landscape reveals unique disease-associated modifications, a new source of potential biomarkers and drug targets, and a method…
-
2 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Alector (NASDAQ:ALEC) shares increased by 9.7% to $2.59 during Tuesday's after-market session. The company's market cap stands at $256.8 million. NeuroSense Therapeutics (NASDAQ:NRSN) shares…
3 months ago seekingalpha.com
Nautilus Biotechnology: Contrarian Proteoformics Play After The Recent Pullback
NAUT is now prioritizing targeted proteoform assays after Broadscale testing failed to support its prior commercialization roadmap. But their roadmap with Voyager is clearer, although Early Access…
3 months ago seekingalpha.com
Nautilus Biotechnology, Inc. (NAUT) Q2 2026 Earnings Call Transcript
Nautilus Biotechnology, Inc. (NAUT) Q2 2026 Earnings Call Transcript
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers OPKO Health (NASDAQ:OPK) shares increased by 34.7% to $1.67 during Tuesday's regular session. The company's market cap stands at $936.3 million. As per the press release, Q2 earnings came out…
3 months ago marketbeat.com
Nautilus Biotechnology Q2 Earnings Call Highlights
Nautilus Biotechnology NASDAQ: NAUT said it is shifting a significant share of its research and development resources toward proteoform applications, citing customer interest and a delay in its…
3 months ago globenewswire.com
Nautilus Biotechnology Reports Second Quarter 2026 Financial Results
SEATTLE, July 28, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the…
-
3 months ago benzinga.com
Nautilus Biotechnology Q2 EPS $(0.11) Beats $(0.14) Estimate, Sales $190.000K
Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.14) by 21.43 percent. This is a 8.33 percent increase over losses…
3 months ago globenewswire.com
Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026
SEATTLE, July 08, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report…
3 months ago benzinga.com
Top 3 Health Care Stocks That May Rocket Higher In July
Oversold health care stocks: EVMN, NNNN, NAUT. RSI <30 shows they may be undervalued. EVMN dropped 46% due to trial failure. NNNN & NAUT had 17% & 12% drops.
5 months ago investorplace.com
3 Small-Cap Stocks to Buy Before May 15
Tom Yeung here with your Sunday Digest.
6 months ago seekingalpha.com
Nautilus Biotechnology, Inc. (NAUT) Q1 2026 Earnings Call Transcript
Nautilus Biotechnology, Inc. (NAUT) Q1 2026 Earnings Call Transcript
6 months ago globenewswire.com
Nautilus Biotechnology Reports First Quarter 2026 Financial Results
SEATTLE, April 28, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the…
6 months ago benzinga.com
Earnings Scheduled For April 28, 2026
Earnings Scheduled For April 28, 2026
6 months ago investorplace.com
Forget Neuralink: The Real Brain Tech Trade Has 10 Names You’ve Never Heard
The real brain computer interface opportunity isn't in the headlines. These 10 stocks are building the systems that make it possible.
6 months ago benzinga.com
Applied Digital, Simply Good Foods And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures lower on Thursday with Applied Digital Corp. (APLD) falling sharply in pre-market trading after beating analyst estimates.
7 months ago globenewswire.com
Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform
• Baylor selects the Nautilus Voyager™ Platform, now available through Early Access Program, for development of a first-in-class computational multi-omics toolkit • NIH-funded project leverages…
8 months ago seekingalpha.com
Nautilus Biotechnology, Inc. (NAUT) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Nautilus Biotechnology, Inc. (NAUT) Presents at TD Cowen 46th Annual Health Care Conference Transcript
-
8 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
-
11 months ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
1 year ago benzinga.com
Earnings Scheduled For October 28, 2025
Earnings Scheduled For October 28, 2025
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session